Search Results - "Colangelo C"

530P Prognostic impact of PIK3CA mutations in patients with endocrine-resistant ER+/HER2- advanced breast cancer: Results from the CHAMBER study.

Authors: Vernaci, G.M. Colangelo, C. Bria, E. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS425-S425. 1p.

Renormalization group equations for effective field theories.

Authors: Büchler, M. Colangelo, C.

Source: European Physical Journal C -- Particles & Fields. Jan2004, Vol. 32 Issue 3, p427-442. 16p.

Uso della Citisina in paziente con disturbo da uso di tabacco severo (DUT) e deficit genetico di alfa-1-antitripsina.

Authors: Campana, M. Bovio, A. Colangelo, C. et al.

Source: Mission (2037-4798). mar2026, Vol. 20 Issue 73, p41-42. 2p.

Il progetto "CYTI-REHAB": il trattamento con Citisina in un contesto ospedaliero.

Authors: Campana, M. Bovio, A. Colangelo, C. et al.

Source: Mission (2037-4798). mar2026, Vol. 20 Issue 73, p39-40. 2p.

Tabagismo e nuovi prodotti del tabacco e della nicotina (sigarette elettroniche, tabacco riscaldato ed altri dispositivi senza combustione): Descrizione di un programma di informazione, prevenzione, formazione e trattamento multimodale della ASST di Bergamo Est.

Authors: Campana, M. Bovio, A. Colangelo, C. et al.

Source: Mission (2037-4798). mar2026, Vol. 20 Issue 73, p30-30. 1p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Awakening giant.

Authors: Colangelo, C. W. Smith, F.

Source: American Gas Association Monthly; February 1966, Vol. 48, p15

The autologous serum skin test in the follow-up of patients with chronic urticaria.

Authors: Fusari, A. Colangelo, C. Bonifazi, F. et al.

Source: Allergy. Feb2005, Vol. 60 Issue 2, p256-258. 3p.

42 Effects of ivacaftor in an adult patient with cystic fibrosis who carries the 3272-26A → G mutation, resulting in residual functioning protein, and has severe lung disease.

Authors: Salvatore, D. Colangelo, C. D'Andria, M. et al.

Source: Journal of Cystic Fibrosis. Jun2017 Supplement 1, Vol. 16, pS74-S74. 1p.

Discovering Novel Inflammatory Triggers after Heart Transplantation Via Proteomics.

Authors: Shen, H. Colangelo, C. Chung, L. et al.

Source: Journal of Heart & Lung Transplantation. Apr2014, Vol. 33 Issue 4, pS164-S164. 1p.

235 Haptoglobin: A Novel Innate Ligand that Induces Inflammation after Tissue Necrosis

Authors: Shen, H. Colangelo, C. Wu, T. et al.

Source: Journal of Heart & Lung Transplantation. Apr2011 Supplement, Vol. 30 Issue 4, pS84-S84. 1p.

Salt depletion syndrome as the initial presentation of cystic fibrosis in a toddler with the rare p.Ala309Gly (A309G) CFTR variant.

Authors: Salvatore, D. Dell'Edera, D. Colangelo, C. et al.

Source: Clinical Genetics. Aug2016, Vol. 90 Issue 2, p186-187. 2p.

The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19.

Authors: Bianconi, V. Mannarino, M. Cosentini, E. et al.

Source: Atherosclerosis (00219150). 2023 Supplement 1, Vol. 379, pS3-S3. 1p.

P037 Elexacaftor/tezacaftor/ivacaftor improve lung disease in patients with advanced cystic fibrosis homozygous for the F508del mutation.

Authors: Carnovale, V. Iacotucci, P. Terlizzi, V. et al.

Source: Journal of Cystic Fibrosis. 2021 Supplement, Vol. 20, pS49-S50. 2p.

WS12.3 Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis severe patients with the F508del/minimal function genotype.

Authors: Carnovale, V. Iacotucci, P. Terlizzi, V. et al.

Source: Journal of Cystic Fibrosis. 2021 Supplement, Vol. 20, pS23-S24. 2p.

P254 Ivacaftor treatment in patients with severe lung disease carrying CFTR mutations with residual function.

Authors: Salvatore, D. Braggion, C. Calderazzo, M.A. et al.

Source: Journal of Cystic Fibrosis. 2019 Supplement 1, Vol. 18, pS128-S129. 2p.

31 Effects of ivacaftor in cystic fibrosis patients carrying a non-G551D gating mutation.

Authors: Iacotucci, P. Salvatore, D. Carnovale, V. et al.

Source: Journal of Cystic Fibrosis. Jun2016 Supplement 1, Vol. 15, pS59-S59. 1p.

Quantitative anatomy and biophysical modeling of ascending neuromodulatory systems in the developing rat neocortex.

Authors: Colangelo C Muñoz A Antonietti A et al.

Source: PLoS computational biology [PLoS Comput Biol] 2026 Jun 26; Vol. 22 (6), pp. e1014460. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE

Penile vascular status in young men living with HIV experiencing erectile dysfunction: A comparative cross-sectional pilot study.

Authors: Tiecco G Delbarba A Colangelo C et al.

Source: Andrology [Andrology] 2026 Feb; Vol. 14 (2), pp. 377-384. Date of Electronic Publication: 2025 Apr 23.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101585129 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-2927 (Electronic) Linking ISSN: 20472919 NLM ISO Abbreviation: Andrology Subsets: MEDLINE